Catalano, Alessia and Iacopetta, Domenico and Sinicropi, Maria Stefania and Franchini, Carlo (2021) Diarylureas as Antitumor Agents. Applied Sciences, 11 (1). p. 374. ISSN 2076-3417
applsci-11-00374.pdf - Published Version
Download (4MB)
Abstract
The diarylurea is a scaffold of great importance in medicinal chemistry as it is present in numerous heterocyclic compounds with antithrombotic, antimalarial, antibacterial, and anti-inflammatory properties. Some diarylureas, serine-threonine kinase or tyrosine kinase inhibitors, were recently reported in literature. The first to come into the market as an anticancer agent was sorafenib, followed by some others. In this review, we survey progress over the past 10 years in the development of new diarylureas as anticancer agents.
Item Type: | Article |
---|---|
Subjects: | EP Archives > Multidisciplinary |
Depositing User: | Managing Editor |
Date Deposited: | 16 Feb 2023 07:21 |
Last Modified: | 17 Jun 2024 05:56 |
URI: | http://research.send4journal.com/id/eprint/812 |